Received Jun 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Y017625 | IM / LA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | 1 | 3CA22C1 | IM / RA |
| YF | YELLOW FEVER (YF-VAX) | SANOFI PASTEUR | 1 | UK134AA | SC / LA |
Client called 5 hours after receiving vaccines and reported redness, swelling, itchiness at site of yellow fever administration, left arm subcutaneous. Client also reported feeling dizzy intermittently. Client denied any respiratory symptoms. Client was instructed to take oral benadryl and apply ice to the site and to call if symptoms worsened or changed. This writer reached out to client following day at 0830, approximately 22 hours after vaccine administration, client reported benadryl helped, swelling decreased. Client reports site is still slightly swollen and itchy. Client instructed to continue to monitor and call back if anything changes.
none reported
PCOS
none reported
allergy to Penincillin and sulfa drugs